Tables

TABLE 1 GLOBAL ONCOLOGY DRUGS MARKET REVENUE BY REGIONS' 2017-2024 ($BILLION) 42
TABLE 1 GLOBAL ONCOLOGY DRUGS MARKET BY VENDOR RANKING' 2017 52
TABLE 2 OTHER PROMINENT VENDORS OF ONCOLOGY DRUGS MARKET 53
TABLE 3 F. HOFFMANN-LA ROCHE: OFFERINGS 54
TABLE 4 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 54
TABLE 5 NOVARTIS AG: OFFERINGS 60
TABLE 6 NOVARTIS AG: RECENT DEVELOPMENTS 61
TABLE 7 BRISTOL-MYERS SQUIBB: OFFERINGS 66
TABLE 8 BRISTOL-MYERS SQUIBB: RECENT DEVELOPMENT 67
TABLE 9 CELGENE CORPORATION: OFFERINGS 73
TABLE 10 CELGENE CORPORATION: RECENT DEVELOPMENTS 73
TABLE 11 JOHNSON & JOHNSON: PRODUCT OFFERINGS 77
TABLE 12 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 78
TABLE 13 PFIZER' INC.: PRODUCT OFFERINGS 84
TABLE 14 PFIZER INC.: RECENT DEVELOPMENTS 85
TABLE 15 ASTRA ZENECA PLC.: SNAPSHOT 90
TABLE 16 ASTRA ZENECA PLC: RECENT DEVELOPMENTS 90
TABLE 17 ELI LILLY AND COMPANY: SNAPSHOT 91
TABLE 18 ELI LILLY AND COMPANY: RECENT DEVELOPMENTS 91
TABLE 19 GLAXOSMITHKLINE PLC.: OVERVIEW 92
TABLE 20 GLAXOSMITHKLINE PLC: RECENT DEVELOPMENTS 93
TABLE 21 MERCK & CO: OVERVIEW 94
TABLE 22 MERCK & CO: RECENT DEVELOPMENTS 94
TABLE 23 SANOFI: SNAPSHOT 95
TABLE 24 SANOFI: RECENT DEVELOPMENTS 96
TABLE 25 AMGEN INC.: SNAPSHOT 97
TABLE 26 AMGEN INC: RECENT DEVELOPMENTS 97
TABLE 27 ABBVIE INC: SNAPSHOT 98
TABLE 28 ABBVIE INC: RECENT DEVELOPMENTS 99

LIST OF FIGURE

Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL ONCOLOGY DRUGS MARKET 12
CHART 2 GLOBAL ONCOLOGY DRUGS MARKET REVENUE' 2017-2024 ($BILLION) 15
CHART 3 NUMBER OF ONCOLOGY DRUGS APPROVED FROM 2014-2017 22
CHART 4 SEGMENTATION OF GLOBAL ONCOLOGY DRUGS MARKET 22
CHART 5 PEST ANALYSIS OF GLOBAL ONCOLOGY DRUGS MARKET 23
CHART 6 PORTER 5 FORCES ON GLOBAL ONCOLOGY DRUGS MARKET 24
CHART 7 DRO - IMPACT ANALYSIS OF GLOBAL ONCOLOGY DRUGS MARKET 29
CHART 8 KEY STAKEHOLDERS 29
CHART 9 GLOBAL ONCOLOGY DRUGS MARKET BY THERAPEUTIC MODALITY SEGMENTATION' 2017 (%) 31
CHART 10 GLOBAL ONCOLOGY DRUGS MARKET BY THERAPEUTIC MODALITY SEGMENTATION' 2024 (%) 31
CHART 11 GLOBAL CHEMOTHERAPY MARKET FORECAST' 2017-2024 ($BILLION) 33
CHART 12 GLOBAL TARGETED THERAPY MARKET FORECAST' 2017-2024 ($BILLION) 34
CHART 13 GLOBAL IMMUNOTHERAPY MARKET FORECAST' 2017-2024 ($BILLION) 35
CHART 14 GLOBAL OTHERS MARKET FORECAST' 2017-2024 ($BILLION) 36
CHART 15 GLOBAL ONCOLOGY DRUGS MARKET BY APPLICATION SEGMENTATION' 2017 (%) 37
CHART 16 GLOBAL ONCOLOGY DRUGS MARKET BY GEOGRAPHICAL SEGMENTATION' 2017 (%) 41
CHART 17 ONCOLOGY DRUGS MARKET REVENUE IN NORTH AMERICA' 2017-2024 ($BILLION) 43
CHART 18 ONCOLOGY DRUGS MARKET REVENUE IN EUROPE' 2017-2024 ($BILLION) 45
CHART 19 ONCOLOGY DRUGS REVENUE IN ASIA-PACIFIC' 2017-2024 ($BILLION) 47
CHART 20 ONCOLOGY DRUGS MARKET REVENUE IN REST OF THE WORLD' 2017-2024 ($BILLION) 50
CHART 25 NOVARTIS AG: OVERVIEW SNAPSHOT 62
CHART 26 NOVARTIS AG: BUSINESS UNITS 63
CHART 27 NOVARTIS GA: GEOGRAPHICAL PRESENCE 63
CHART 28 NOVARTIS AG: SWOT ANALYSIS 64
CHART 29 BRISTOL-MYERS SQUIBB.: OVERVIEW SNAPSHOT 68
CHART 30 BRISTOL-MYERS SQUIBB.: BUSINESS SEGMENTS 69
CHART 31 BRISTOL-MYERS SQUIBB.: GEOGRAPHIC PRESENCE 70
CHART 32 BRISTOL-MYERS SQUIBB.: SWOT ANALYSIS 71
CHART 33 CELGENE CORPORATION: OVERVIEW SNAPSHOT 74
CHART 34 CELGENE CORPORATION: GEOGRAPHIC PRESENCE 75
CHART 35 CELGENE CORPORATION: SWOT ANALYSIS 75
CHART 36 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 80
CHART 37 JOHNSON & JOHNSON: BUSINESS UNITS 80
CHART 38 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 81
CHART 39 JOHNSON & JOHNSON: SWOT ANALYSIS 83
CHART 40 PFIZER INC.': OVERVIEW SNAPSHOT 86
CHART 41 PFIZER INC.: BUSINESS UNITS REVENUE 87
CHART 42 PFIZER INC.: GEOGRAPHICAL PRESENCE 87
CHART 43 PFIZER INC.: SWOT ANALYSIS 89